Johansson Bengt, Ridderheim Mona, Glimelius Bengt
Department of General Oncology, Orebro University Hospital, Orebro, Sweden.
Acta Oncol. 2005;44(8):890-5. doi: 10.1080/02841860500355942.
A group of Swedish oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy. The estimations have been based on current statistics of tumour incidence, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the dose-response relations of different tumours and normal tissues. In prostate cancer it is estimated that annually about 300 patients and in gynaecological cancer about 50 patients, are candidates for proton beam therapy. Owing to major uncertainties, it has not been possible to give an estimate of the number of potential patients with urinary bladder cancer.
一群瑞典肿瘤学家和医院物理学家估算了瑞典适合质子束治疗的患者数量。估算基于当前肿瘤发病率统计数据、可能符合放射治疗条件的患者数量、临床试验的科学支持以及模型剂量规划研究,还有不同肿瘤和正常组织的剂量反应关系的知识。据估计,在前列腺癌方面,每年约有300名患者适合质子束治疗,在妇科癌症方面约有50名患者适合。由于存在重大不确定性,目前还无法给出膀胱癌潜在患者数量的估计值。